Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

NCT07475962 is registered in ClinicalTrials.gov with Institut de Recherches Cliniques de Montreal as lead sponsor.

NCT NCT07475962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07475962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes
Lead sponsor
Institut de Recherches Cliniques de Montreal
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
May 30, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

latent autoimmune diabetes in adult (lada), liver fibrosis, liver steatoses, masld - metabolic dysfunction-associated steatotic liver disease, type 1 diabetes